Members of the HDAC family exhibit subtype-specific abnormalities in bladder cancer: Class I HDACs (HDAC1, 2, 3) are overexpressed in 40%–59% of bladder cancers. This evidence concerns the gene HDAC1 and urinary bladder cancer.